Enhancing Heart Health: Expanding the Use of SGLT2 Inhibitors in Cardiovascular Disease

Manahil Mubeen, Aasiya Shahbaz Sakarwala, Arif Imdad Bijarani, Muhammad Taha Kamal
{"title":"Enhancing Heart Health: Expanding the Use of SGLT2 Inhibitors in Cardiovascular Disease","authors":"Manahil Mubeen,&nbsp;Aasiya Shahbaz Sakarwala,&nbsp;Arif Imdad Bijarani,&nbsp;Muhammad Taha Kamal","doi":"10.1002/med4.70014","DOIUrl":null,"url":null,"abstract":"<p>SGLT2 inhibitors offer multifaceted cardiovascular benefits, including improved cardiac metabolism, reduced preload and afterload, and decreased myocardial infarction risk. These effects are driven by renoprotection, anti-inflammatory properties, improved mitochondrial function, osmotic diuresis, and glycemic control. Together, these mechanisms support the role of SGLT2 inhibitors in reducing cardiovascular morbidity and mortality.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":100913,"journal":{"name":"Medicine Advances","volume":"3 2","pages":"122-126"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/med4.70014","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine Advances","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/med4.70014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0

Abstract

SGLT2 inhibitors offer multifaceted cardiovascular benefits, including improved cardiac metabolism, reduced preload and afterload, and decreased myocardial infarction risk. These effects are driven by renoprotection, anti-inflammatory properties, improved mitochondrial function, osmotic diuresis, and glycemic control. Together, these mechanisms support the role of SGLT2 inhibitors in reducing cardiovascular morbidity and mortality.

Abstract Image

增强心脏健康:扩大SGLT2抑制剂在心血管疾病中的应用
SGLT2抑制剂提供多方面的心血管益处,包括改善心脏代谢,减少前负荷和后负荷,降低心肌梗死风险。这些作用是由肾保护、抗炎特性、改善线粒体功能、渗透性利尿和血糖控制驱动的。总之,这些机制支持SGLT2抑制剂在降低心血管发病率和死亡率中的作用。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信